Elrayah-Eliadarous H, Yassin K, Eltom M, Abdelrahman S, Wahlström R, Ostenson C-G
Division of International Health (IHCAR), Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.
Exp Clin Endocrinol Diabetes. 2010 Apr;118(4):220-5. doi: 10.1055/s-0029-1246216. Epub 2010 Feb 5.
The aim of this study was to estimate the contribution by type 2 diabetic patients in a low-income country from their own income in attempting to control the disease and to prevent chronic diabetes complications through good glycaemic control. Socio-economic and demographic data for study subjects were obtained from 822 adult diabetic patients attending public or private diabetic clinics in Khartoum State, Sudan. The average annual income of diabetic patients was estimated as USD 1.923. The direct cost of diabetes control was USD 175 per year. This included cost of drugs and ambulatory care, although drug supply was insufficient for 52% of the patients. Glycosylated hemoglobin as a measure of glycaemic control was determined to be unsatisfactory in 77% of patients. This gives an immediate indication that current practices in diabetes control in urban Sudan are not cost-effective. Patients attending private clinics had a higher income and cost of diabetes control than those attending public clinics. However, both groups had similar proportion of poor glycaemic control, which reflects the insufficient care given to diabetic patients, mainly due to deficient resources and inefficient utilization of what is scarcely available.
本研究的目的是评估低收入国家中2型糖尿病患者用自身收入控制疾病并通过良好的血糖控制预防慢性糖尿病并发症的贡献。研究对象的社会经济和人口数据来自苏丹喀土穆州822名就诊于公立或私立糖尿病诊所的成年糖尿病患者。糖尿病患者的年均收入估计为1923美元。糖尿病控制的直接成本为每年175美元。这包括药物和门诊护理费用，尽管52%的患者药物供应不足。作为血糖控制指标的糖化血红蛋白在77%的患者中被判定为不理想。这直接表明苏丹城市目前的糖尿病控制做法不具有成本效益。就诊于私立诊所的患者比就诊于公立诊所的患者收入更高且糖尿病控制成本更高。然而，两组血糖控制不佳的比例相似，这反映出对糖尿病患者的护理不足，主要原因是资源匮乏以及对稀缺资源利用效率低下。
